|
William W. Freimuth joined HGS in August 2000 as Director of Clinical Research Immunology and Infectious Diseases. In December 2003 he was promoted to Vice President Clinical Research Immunology Rheumatology and Infectious Diseases. Before coming to HGS Dr. Freimuth was with Pharmacia & Upjohn most recently serving as Therapeutic Area Clinical Director Antiviral. He joined the Phase 1/2 clinical research unit of Upjohn in 1992 and during his tenure at Pharmacia & Upjohn held a number of clinical research management positions including responsibility for worldwide clinical development of four antiviral agents. From 1986-1992 Dr. Freimuth completed his Residency in Internal Medicine and his Rheumatology fellowship training at the University of Michigan Medical Center in Ann Arbor. Dr. Freimuth earned his M.D. from the State University of New York at Buffalo (SUNYAB) School of Medicine where he subsequently did postdoctoral research in immunology and immunogenetics. Dr. Freimuth received his Ph.D. in Immunology from Michigan State University and his B.S. in microbiology from the University of Michigan. | 